Prevalence of metallo-beta-lactamases (MBLS) producing Pseudomonas aeruginosa in hospitalized patients in rural tertiary care hospital in Uttar Pradesh, India

Sarita Sinha; Amit Singh; Rajesh Kumar Verma; Dharmendra Prasad Singh; Sunita Kumari

doi:10.18203/2320-6012.ijrms20183652

Authors

Sarita Sinha Department of Microbiology, UPUMS, Saifai, Etawah, Uttar Pradesh, India
Amit Singh Department of Microbiology, UPUMS, Saifai, Etawah, Uttar Pradesh, India
Rajesh Kumar Verma Department of Microbiology, UPUMS, Saifai, Etawah, Uttar Pradesh, India
Dharmendra Prasad Singh Department of Microbiology, UPUMS, Saifai, Etawah, Uttar Pradesh, India
Sunita Kumari Department of Microbiology, UPUMS, Saifai, Etawah, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20183652

Keywords:

Carbapenem, CDST, DDST, E-test MBL, IPM, MBLs, MHT

Abstract

Background: Pseudomonas aeruginosa is a leading cause of nosocomial infections due to MBLs production with limited therapeutic options, higher rate of colonization is encountered in hospitalized patient streated with broad spectrum antibiotics. This study was conducted with an aim to know the prevalence of Carbapenem resistant MBLs producing strains of Pseudomonas aeruginosa in hospitalized patients.

Methods: A total of 14700 samples were obtained from various wards during Jan 2016 to June 2017, were screened for P. aeruginosa by conventional culture and biochemical tests. All confirmed P. aeruginosa isolates were further subjected to Modified Kirby- Bauer disc diffusion test as per CLSI guidelines. All IPM resistant isolates were screened for MBL production by DDST, CDST, MHT and E-test MBL.

Results: Atotal of 1423were identified as P. aeruginosa. The isolation rate of P. aeruginosa at our hospital was 9.7%. Among these, 130(9.1%) isolates were IPM resistant. A total of 111 (85.4%) were MBL positive by CDST and E-test, 92 (70.5%) by DDST and 80 (61.5%) by MHT. The prevalence of MBL producing P. aeruginosa was 111/1423(7.8%) while among IPM resistant P. aeruginosa, its prevalence was 111/130 (85.4%).

Conclusions: The study documents presence of nosocomial MBL producing P. aeruginosa strains in our Institute. E-test and CDST were superior to DDST and MHT for detection of MBLs.

Metrics

Metrics Loading ...

References

Valenza G, Joseph B, Elias J, Claus H, Oesterlein A, Engelhardt K, et al. First survey of metallo-β-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital. Antimicrobial agents and chemotherapy. 2010 Aug 1;54(8):3493-7.

Pitout JD, Gregson DB, Poirel L, McClure JA, Le P, Church DL. Detection of Pseudomonas aeruginosa producing metallobeta-lactamases in a large centralized laboratory. J Clin Microbiol. 2005;43:3129-35.

Livermore DM, Woodford N. Carbapenemases: a problem in waiting? Curr Opin Microbiol. 2000;3:489-95.

Lee K, Chong Y, Shin HB, Kim YA, Yong D, Yum JH. Modified Hodge and EDTA-disk synergy tests to screen metallo-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect. 2001;7:88-91.

Behera B, Mathur P, Das A, Kapil A, Sharma V. An evaluation of four different phenotypic techniques for detection of metallo-β-lactamase producing Pseudomonas aeruginosa. Ind J Med Microbiol. 2008 Jul 1;26(3):233.

Lee K, Lim YS, Yong D, Yum JH, Chong Y. Evaluation of the Hodge test and imipenem-EDTA-disk synergry test for differentiating metallo- beta-lactamase producing isolates of Pseudomonas Spp and Acinetobacter spp. J clin Microbiol. 2003;414623-9.

Ranjan S, Banashankari GS, Babu PR. Evaluation of phenotypic tests and screening markers for detection of metallo-β-lactamases in clinical isolates of Pseudomonas aeruginosa: A prospective study. Med J Dr. DY Patil University. 2015 Sep 1;8(5):599.

Gupta V, Datta P, Chander J. Prevalence of metallo-beta lactamase (MBL) producing Pseudomonas spp and Acinetobacter spp.in a tertiary care hospital in India. J Infect. 2006;52:311-4.

Basak S, Khodke M, Bose S, Mallick SK. Inducible Amp-C beta-lactamase producing Pseudomonas aeruginosa isolated in a rural hospital of central India. J Clin Diagn Res. 2009;3:1921-7.

Javiya VA, Ghatak SB, Patel kr, Patel JA. Antibiotic susceptiblity patterns of Pseudomonas aeuginosa at a tertiary care hospital in Gujrat, India. Indian J Pharmacol. 2008;40(5):230-4.

Kali A, Srirangaraj S, Kumar S, Divya HA, Kalyani A, Umadevi S. Detection of metallo-beta lacatmase producing Pseudomonas aeruginosa in intensive care units. Australas Med J. 2013;6(12):686-93.

Tsakris A, Poulou A, Krist I, Pittaras T, Spanakis N, Pournara S, et al. Large dissemination of VIM-2 metallo-beta-lactamases producing pseudomonas aeruginosa strains causing health care-associated community onset infection. J Clin Microbiol. 2009;47(11):3524-9.

Samporn S, Chuntima T, Thitiya Y, Chertask D. Prevalence and antimicrobial susceptibility of Pseudomonas aeruginosa mucoid and non-mucoid type. Southeast Asia J Trop Med and Public Health. 2004;35:893-4.

Srinivas B, Lalitha devi D, Narasinga Rao B. A prospective study of Pseudomonas aeruginosa and its antibiogram in a teaching hospital of Rural setup. J Pharma and Biomed Sci. 2012;22(18):23-9.